{
  "zip": "91365",
  "sector": "Healthcare",
  "fullTimeEmployees": 1,
  "longBusinessSummary": "Inspyr Therapeutics, Inc., clinical-stage pharmaceutical company, focuses on the development of therapeutics for the treatment of diseases. It focuses on a pipeline of small molecule adenosine receptor modulators, such as A2B antagonists, dual A2A/A2B antagonists, and A2A agonists. The company was formerly known as GenSpera Inc. and changed its name to Inspyr Therapeutics, Inc. in August 2016. Inspyr Therapeutics, Inc. was founded in 2003 and is based in Westlake Village, California.",
  "city": "Westlake Village",
  "phone": "818 597 7552",
  "state": "CA",
  "country": "United States",
  "companyOfficers": [],
  "maxAge": 1,
  "address1": "31200 Via Colinas",
  "industry": "Biotechnology",
  "address2": "Suite 200",
  "previousClose": 0.0074,
  "regularMarketOpen": 0.0076,
  "twoHundredDayAverage": 0.021074072,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 0.0077,
  "navPrice": null,
  "averageDailyVolume10Day": 31183857,
  "totalAssets": null,
  "regularMarketPreviousClose": 0.0074,
  "fiftyDayAverage": 0.007843333,
  "trailingAnnualDividendRate": null,
  "open": 0.0076,
  "averageVolume10days": 31183857,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": -16.540966,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 0.0069,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 15203161,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 1050000,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 8870324,
  "priceToSalesTrailing12Months": null,
  "dayLow": 0.0069,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 15203161,
  "fiftyTwoWeekHigh": 0.7,
  "forwardPE": -0.024137933,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 0.0005,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 0.0077,
  "exchange": "PNK",
  "shortName": "INSPYR THERAPEUTIC",
  "longName": "Inspyr Therapeutics, Inc.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "NSPX",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_49371601",
  "uuid": "3ca1f1a0-b0f8-36cd-9f3e-247a1e5838b7",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": -7.401,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": -0.29,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 150000000,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": -0.178,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1577750400,
  "heldPercentInstitutions": 0.00025,
  "netIncomeToCommon": -291000,
  "trailingEps": -0.169,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0,
  "nextFiscalYearEnd": 1640908800,
  "mostRecentQuarter": 1601424000,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 85000500,
  "enterpriseValue": 3249000,
  "threeYearAverageReturn": null,
  "lastSplitDate": 1593475200,
  "lastSplitFactor": "1:30",
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": 4.002,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 0.0076,
  "logo_url": ""
}